♥
ISIN : INE544H01014
NSE : JHS
BSE : 532771
Face Value : 10
Industry : Household & Personal Products
EPS : -0.52
EPS (TTM) : -0.27
Price to Earning (P/E) : -21.50
Book Value : 21.67
Price to Bookvalue (P/B) : 0.52
Dividend Yield : 0 %
Return on Equity (ROE) : -2.36 %
Return on Capital Employed (ROCE) : -1.71 %
JHS Svendgaard Laboratories Limited
ISIN : INE544H01014
NSE : JHS
BSE : 532771
Face Value : 10
Industry : Household & Personal Products
EPS : -0.52
EPS (TTM) : -0.27
Price to Earning (P/E) : -21.50
Book Value : 21.67
Price to Bookvalue (P/B) : 0.52
Dividend Yield : 0 %
Return on Equity (ROE) : -2.36 %
Return on Capital Employed (ROCE) : -1.71 %
JHS Svendgaard share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 8.68 - 7.75 -10.7 % |
| Low / High | 6.45 - 8.68 34.6 % |
| Trade Volume | 20,026 |
| 52 Week Low / High | 6.15 - 16.2 163.4 % |
-
YOU MAY ALSO LIKE
- How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - Share Market basics for beginners
Share Market jargons in simple terms - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - Stock market course tutorial
Stock Market Investment Course explained in simple words. - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
CONSOLIDATED QUARTERLY RESULT FOR JHS SVENDGAARD LABORATORIES LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 191.14 | 213.09 | 240.53 | 254.46 | 253.99 | 190.28 | 189.3 | 143 | 216.63 | 244.84 |
| Total Income | 214.95 | 227.86 | 274.91 | 271.19 | 332.09 | 203.66 | 191.26 | 166.4 | 230.37 | 248.04 |
| Total Expenditure | 192.59 | 227.66 | 265.42 | 272.85 | 282.5 | 220.52 | 185.24 | 143.59 | 208.27 | 225.15 |
| Other Income | 23.8 | 14.77 | 34.38 | 16.72 | 78.1 | 13.37 | 1.95 | 23.4 | 13.74 | 3.2 |
| Operating Profit | 22.36 | 0.2 | 9.49 | -1.66 | 49.59 | -16.86 | 6.02 | 22.81 | 22.1 | 22.89 |
| Interest | 6.09 | 6.84 | 1.88 | 2.45 | 3.89 | 2.26 | 0.96 | 1.07 | 1.29 | 1.17 |
| Exceptional Items | -186.31 | |||||||||
| PBDT | 16.27 | -6.64 | 7.61 | -4.11 | -140.61 | -19.12 | 5.06 | 21.74 | 20.81 | 21.72 |
| Depreciation | 16.86 | 17.02 | 17.42 | 17.1 | 23.12 | 17.41 | 14.99 | 16.25 | 19.01 | 19.72 |
| Profit Before Tax | -0.59 | -23.66 | -9.81 | -21.21 | -163.73 | -36.53 | -9.93 | 5.49 | 1.8 | 2 |
| Tax | 43.74 | 17.92 | -5.73 | -0.4 | -62.44 | -6.23 | -2.64 | 5.37 | 9.31 | 8.29 |
| Profit After Tax | -44.33 | -41.58 | -4.08 | -20.81 | -101.29 | -30.3 | -7.29 | 0.12 | -7.51 | -6.29 |
| Net Profit | -44.33 | -41.58 | -4.08 | -20.81 | -101.29 | -30.3 | -7.29 | 0.12 | -7.51 | -6.29 |
| Equity Capital | 649 | 649.01 | 649.01 | 649.01 | 649.01 | 649.01 | 783.97 | 783.97 | 783.97 | 783.97 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | -0.67 | -0.59 | -0.03 | -0.24 | -1.52 | -0.42 | -0.09 | 0 | -0.1 | -0.08 |
| Diluted Eps After Extraordinary Items | -0.68 | -0.59 | -0.03 | -0.24 | -1.52 | -0.4 | -0.09 | -0.1 | -0.08 | |
| Diluted Eps Before Extraordinary Items | -0.68 | -0.59 | -0.03 | -0.24 | -1.52 | -0.4 | -0.09 | -0.1 | -0.08 |
STANDALONE QUARTERLY RESULT FOR JHS SVENDGAARD LABORATORIES LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 172.52 | 192.05 | 208.52 | 212.55 | 206.04 | 147.63 | 189.3 | 143 | 216.63 | 244.84 |
| Total Income | 192.6 | 203.91 | 237.4 | 226.69 | 281.8 | 157.83 | 191.26 | 166.4 | 230.37 | 248.04 |
| Total Expenditure | 175.41 | 201.59 | 228.21 | 229.03 | 239.6 | 167.55 | 185.23 | 143.57 | 208.23 | 225.14 |
| Other Income | 20.08 | 11.86 | 28.88 | 14.14 | 75.76 | 10.2 | 1.95 | 23.4 | 13.74 | 3.2 |
| Operating Profit | 17.19 | 2.32 | 9.19 | -2.34 | 42.2 | -9.72 | 6.03 | 22.83 | 22.14 | 22.9 |
| Interest | 1.41 | 1.17 | 0.83 | 1.22 | 0.78 | 0.94 | 0.96 | 1.07 | 1.29 | 1.17 |
| Exceptional Items | -186.31 | |||||||||
| PBDT | 15.78 | 1.15 | 8.36 | -3.56 | -144.89 | -10.66 | 5.07 | 21.76 | 20.85 | 21.73 |
| Depreciation | 14.44 | 14.05 | 14.38 | 14.14 | 15.66 | 12.76 | 14.99 | 16.25 | 19.01 | 19.72 |
| Profit Before Tax | 1.34 | -12.9 | -6.02 | -17.7 | -160.55 | -23.42 | -9.92 | 5.51 | 1.84 | 2.01 |
| Tax | 38.04 | 20.33 | -0.17 | 0.24 | -66.19 | -3.99 | -2.64 | 5.37 | 9.31 | 8.29 |
| Profit After Tax | -36.7 | -33.23 | -5.85 | -17.94 | -94.36 | -19.43 | -7.28 | 0.14 | -7.47 | -6.28 |
| Net Profit | -36.7 | -33.23 | -5.85 | -17.94 | -94.36 | -19.43 | -7.28 | 0.14 | -7.47 | -6.28 |
| Equity Capital | 649.01 | 649.01 | 649.01 | 649.01 | 649.01 | 649.01 | 783.97 | 783.97 | 783.97 | 783.97 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | -0.57 | -0.51 | -0.09 | -0.28 | -1.45 | -0.3 | -0.09 | 0 | -0.1 | -0.08 |
| Diluted Eps After Extraordinary Items | -0.57 | -0.51 | -0.09 | -0.28 | -1.45 | -0.3 | -0.09 | -0.1 | -0.08 | |
| Diluted Eps Before Extraordinary Items | -0.57 | -0.51 | -0.09 | -0.28 | -1.45 | -0.3 | -0.09 | -0.1 | -0.08 |
CONSOLIDATED ANNUAL RESULT FOR JHS SVENDGAARD LABORATORIES LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 862.52 | 962.07 | 707.98 |
| Total Income | 956.42 | 1106.04 | 751.13 |
| Total Expenditure | 870.93 | 1053.08 | 717.34 |
| Other Income | 93.9 | 143.98 | 43.14 |
| Operating Profit | 85.49 | 52.96 | 33.79 |
| Interest | 13.94 | 10.42 | 4.6 |
| Exceptional Items | -186.31 | ||
| PBDT | 71.55 | -143.77 | 29.19 |
| Depreciation | 70.52 | 74.65 | 63.46 |
| Profit Before Tax | 1.03 | -218.42 | -34.27 |
| Tax | 43.92 | -50.65 | 6.29 |
| Profit After Tax | -42.89 | -167.77 | -40.56 |
| Net Profit | -42.89 | -167.77 | -40.56 |
| Equity Capital | 649.01 | 649.01 | 783.97 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Calculated EPS | -0.62 | -2.38 | -0.52 |
| Diluted Eps After Extraordinary Items | -0.63 | -2.34 | -0.52 |
| Diluted Eps Before Extraordinary Items | -0.63 | -2.34 | -0.52 |
STANDALONE ANNUAL RESULT FOR JHS SVENDGAARD LABORATORIES LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 799.06 | 819.16 | 707.98 |
| Total Income | 880.5 | 949.79 | 751.13 |
| Total Expenditure | 797.3 | 898.45 | 717.27 |
| Other Income | 81.44 | 130.63 | 43.14 |
| Operating Profit | 83.2 | 51.34 | 33.86 |
| Interest | 4.99 | 4 | 4.6 |
| Exceptional Items | -186.31 | ||
| PBDT | 78.21 | -138.97 | 29.26 |
| Depreciation | 58.96 | 58.24 | 63.46 |
| Profit Before Tax | 19.25 | -197.21 | -34.2 |
| Tax | 43.51 | -45.78 | 6.29 |
| Profit After Tax | -24.26 | -151.43 | -40.49 |
| Net Profit | -24.26 | -151.43 | -40.49 |
| Equity Capital | 649.01 | 649.01 | 783.97 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Calculated EPS | -0.37 | -2.33 | -0.52 |
| Diluted Eps After Extraordinary Items | -0.38 | -2.33 | -0.52 |
| Diluted Eps Before Extraordinary Items | -0.38 | -2.33 | -0.52 |
CONSOLIDATED PROFIT / LOSS FOR JHS SVENDGAARD LABORATORIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 100.92 Cr | 86.5 Cr | 96.21 Cr | 70.8 Cr |
| Sales | 100.22 Cr | 85.74 Cr | 95.47 Cr | 69.81 Cr |
| Job Work/ Contract Receipts | 49,000 | 0 | 0 | 0 |
| Net Sales | 100.76 Cr | 86.25 Cr | 96.21 Cr | 70.8 Cr |
| Increase/Decrease in Stock | 95.56 Lk | -78.21 Lk | -50.13 Lk | 80.94 Lk |
| Raw Material Consumed | 44.57 Cr | 39.74 Cr | 42.96 Cr | 25.34 Cr |
| Opening Raw Materials | 26.86 Lk | 4.06 Cr | 3.56 Cr | 3.82 Cr |
| Purchases Raw Materials | 45.01 Cr | 31.64 Cr | 32.89 Cr | 24.24 Cr |
| Closing Raw Materials | 4.06 Cr | 3.56 Cr | 3.82 Cr | 5.25 Cr |
| Other Direct Purchases / Brought in cost | 3.36 Cr | 7.6 Cr | 10.33 Cr | 2.53 Cr |
| Power & Fuel Cost | 2.98 Cr | 2.91 Cr | 2.98 Cr | 2.73 Cr |
| Electricity & Power | 2.98 Cr | 2.91 Cr | 2.98 Cr | 2.73 Cr |
| Employee Cost | 10.08 Cr | 11.45 Cr | 15.25 Cr | 9.21 Cr |
| Salaries, Wages & Bonus | 8.48 Cr | 10.27 Cr | 14.72 Cr | 8.22 Cr |
| Contributions to EPF & Pension Funds | 56.14 Lk | 64.97 Lk | 58.72 Lk | 48.79 Lk |
| Workmen and Staff Welfare Expenses | 64 Lk | 15.07 Lk | 17.34 Lk | 23.35 Lk |
| Other Manufacturing Expenses | 30.4 Cr | 28 Cr | 33.41 Cr | 25.12 Cr |
| Processing Charges | 5.25 Cr | 4.79 Cr | 6.6 Cr | 5.02 Cr |
| Repairs and Maintenance | 2.18 Cr | 1.57 Cr | 2.79 Cr | 1.68 Cr |
| Packing Material Consumed | 22.81 Cr | 21.54 Cr | 23.4 Cr | 18 Cr |
| General and Administration Expenses | 4.14 Cr | 4.28 Cr | 9.32 Cr | 3.43 Cr |
| Rent , Rates & Taxes | 67.43 Lk | 36.82 Lk | 64.87 Lk | 34.6 Lk |
| Insurance | 56.14 Lk | 54.63 Lk | 57.31 Lk | 48 Lk |
| Printing and stationery | 6.58 Lk | 8.66 Lk | 9.16 Lk | 6.44 Lk |
| Professional and legal fees | 1.27 Cr | 1 Cr | 3.98 Cr | 1.18 Cr |
| Traveling and conveyance | 43.39 Lk | 82.94 Lk | 96.61 Lk | 87.76 Lk |
| Selling and Distribution Expenses | 89.12 Lk | 1.23 Cr | 2.78 Cr | 1.17 Cr |
| Advertisement & Sales Promotion | 42.66 Lk | 24.38 Lk | 1.79 Cr | 28.45 Lk |
| Sales Commissions & Incentives | 0 | 0 | 46.66 Lk | 58.88 Lk |
| Freight and Forwarding | 21.17 Lk | 42.92 Lk | 52.91 Lk | 29.41 Lk |
| Miscellaneous Expenses | 4.83 Cr | 12.53 Cr | 1.11 Cr | 3.92 Cr |
| Bad debts /advances written off | 3.29 Cr | 12.26 Cr | 0 | 0 |
| Provision for doubtful debts | 6.87 Lk | 0 | 3.01 Lk | 19,000 |
| Loss on disposal of fixed assets(net) | 5.03 Lk | 0 | 14.15 Lk | 0 |
| Loss on foreign exchange fluctuations | 0 | 0 | 0 | 11.97 Lk |
| Total Expenditure | 98.85 Cr | 99.36 Cr | 107.31 Cr | 71.73 Cr |
| Other Income | 7.54 Cr | 21.65 Cr | 16.4 Cr | 4.31 Cr |
| Interest Received | 82.98 Lk | 2.2 Cr | 1.03 Cr | 56.07 Lk |
| Profit on sale of Fixed Assets | 0 | 0 | 0 | 15,000 |
| Profits on sale of Investments | 19.98 Lk | 1.22 Lk | 5.27 Lk | 0 |
| Provision Written Back | 4.7 Cr | 14.49 Cr | 2.15 Cr | 52.14 Lk |
| Foreign Exchange Gains | 0 | 65.29 Lk | 89.99 Lk | 1,000 |
| Operating Profit | 9.46 Cr | 8.55 Cr | 5.3 Cr | 3.38 Cr |
| Interest | 1.24 Cr | 1.39 Cr | 1.04 Cr | 46.06 Lk |
| Bank Charges etc | 0 | 12.4 Lk | 8.1 Lk | 3.56 Lk |
| PBDT | 8.22 Cr | 7.16 Cr | 4.26 Cr | 2.92 Cr |
| Depreciation | 7.25 Cr | 7.05 Cr | 7.46 Cr | 6.35 Cr |
| Profit Before Taxation & Exceptional Items | 96.78 Lk | 10.3 Lk | -3.21 Cr | -3.43 Cr |
| Exceptional Income / Expenses | 0 | 0 | -18.63 Cr | 0 |
| Profit Before Tax | 96.78 Lk | 10.3 Lk | -21.84 Cr | -3.43 Cr |
| Provision for Tax | -37.46 Lk | 4.39 Cr | -5.06 Cr | 62.91 Lk |
| Current Income Tax | 52.57 Lk | 92.09 Lk | 12.87 Lk | 0 |
| Deferred Tax | 41.39 Lk | 3.46 Cr | -5.19 Cr | 62.91 Lk |
| Profit After Tax | 1.34 Cr | -4.29 Cr | -16.78 Cr | -4.06 Cr |
| Minority Interest | -14.42 Lk | 23.74 Lk | 1.31 Cr | 1.31 Cr |
| Consolidated Net Profit | 1.2 Cr | -4.05 Cr | -15.46 Cr | -2.75 Cr |
| Profit Balance B/F | 15.17 Cr | 17.7 Cr | 14.12 Cr | -11.93 Cr |
| Appropriations | 16.37 Cr | 13.65 Cr | -1.35 Cr | -14.67 Cr |
| Other Appropriation | -1.33 Cr | -46.7 Lk | -10.03 Cr | 1.26 Cr |
| Earnings Per Share | 0.19 | -0.62 | -2.38 | -0.35 |
| Adjusted EPS | 0.19 | -0.62 | -2.38 | -0.35 |
STANDALONE PROFIT / LOSS FOR JHS SVENDGAARD LABORATORIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 97.12 Cr | 80.15 Cr | 81.92 Cr | 70.8 Cr |
| Sales | 96.42 Cr | 79.39 Cr | 81.18 Cr | 69.81 Cr |
| Job Work/ Contract Receipts | 49,000 | 0 | 0 | 0 |
| Net Sales | 96.96 Cr | 79.91 Cr | 81.92 Cr | 70.8 Cr |
| Increase/Decrease in Stock | 54.32 Lk | 6.96 Lk | -41.45 Lk | 80.94 Lk |
| Raw Material Consumed | 43.47 Cr | 35.25 Cr | 35.91 Cr | 25.34 Cr |
| Opening Raw Materials | 26.86 Lk | 4.06 Cr | 3.56 Cr | 3.82 Cr |
| Purchases Raw Materials | 45.01 Cr | 31.64 Cr | 32.89 Cr | 24.24 Cr |
| Closing Raw Materials | 4.06 Cr | 3.56 Cr | 3.82 Cr | 5.25 Cr |
| Other Direct Purchases / Brought in cost | 2.26 Cr | 3.1 Cr | 3.27 Cr | 2.53 Cr |
| Power & Fuel Cost | 2.92 Cr | 2.81 Cr | 2.88 Cr | 2.73 Cr |
| Electricity & Power | 2.92 Cr | 2.81 Cr | 2.88 Cr | 2.73 Cr |
| Employee Cost | 8.38 Cr | 9.93 Cr | 9.18 Cr | 9.21 Cr |
| Salaries, Wages & Bonus | 6.95 Cr | 8.87 Cr | 8.77 Cr | 8.22 Cr |
| Contributions to EPF & Pension Funds | 47.41 Lk | 55.92 Lk | 53.76 Lk | 48.79 Lk |
| Workmen and Staff Welfare Expenses | 63.54 Lk | 14.46 Lk | 16.22 Lk | 23.35 Lk |
| Other Manufacturing Expenses | 30.25 Cr | 27.83 Cr | 33.27 Cr | 25.09 Cr |
| Processing Charges | 5.25 Cr | 4.79 Cr | 6.6 Cr | 5.02 Cr |
| Repairs and Maintenance | 2.07 Cr | 1.4 Cr | 2.68 Cr | 1.68 Cr |
| Packing Material Consumed | 22.81 Cr | 21.54 Cr | 23.4 Cr | 18 Cr |
| General and Administration Expenses | 2.87 Cr | 2.95 Cr | 6.3 Cr | 3.36 Cr |
| Rent , Rates & Taxes | 62.5 Lk | 25.47 Lk | 52.07 Lk | 27.98 Lk |
| Insurance | 55.26 Lk | 53.6 Lk | 56.45 Lk | 48 Lk |
| Printing and stationery | 5.61 Lk | 7.89 Lk | 8.15 Lk | 6.44 Lk |
| Professional and legal fees | 74.08 Lk | 77.36 Lk | 3.75 Cr | 1.2 Cr |
| Traveling and conveyance | 34.26 Lk | 73.53 Lk | 89.76 Lk | 88.27 Lk |
| Selling and Distribution Expenses | 30.69 Lk | 39.74 Lk | 1.77 Cr | 1.25 Cr |
| Advertisement & Sales Promotion | 15.23 Lk | 20.13 Lk | 1.41 Cr | 28.45 Lk |
| Sales Commissions & Incentives | 0 | 0 | 0 | 58.88 Lk |
| Freight and Forwarding | 15.46 Lk | 19.61 Lk | 36.49 Lk | 31.55 Lk |
| Miscellaneous Expenses | 4.55 Cr | 12.76 Cr | 94.17 Lk | 3.92 Cr |
| Provision for doubtful debts | 0 | 0 | 0 | 19,000 |
| Loss on disposal of fixed assets(net) | 5.03 Lk | 0 | 0 | 0 |
| Loss on foreign exchange fluctuations | 73.5 Lk | 0 | 0 | 11.97 Lk |
| Total Expenditure | 93.3 Cr | 91.99 Cr | 89.84 Cr | 71.73 Cr |
| Other Income | 5.55 Cr | 20.41 Cr | 13.06 Cr | 4.31 Cr |
| Interest Received | 29.94 Lk | 2.48 Cr | 3.09 Cr | 56.07 Lk |
| Profit on sale of Fixed Assets | 0 | 0 | 3.89 Lk | 15,000 |
| Profits on sale of Investments | 15.11 Lk | 62,000 | 4.16 Lk | 0 |
| Provision Written Back | 4.18 Cr | 14.36 Cr | 26.89 Lk | 52.14 Lk |
| Foreign Exchange Gains | 0 | 65.29 Lk | 89.98 Lk | 0 |
| Operating Profit | 9.21 Cr | 8.32 Cr | 5.14 Cr | 3.38 Cr |
| Interest | 45.25 Lk | 49.94 Lk | 39.98 Lk | 46 Lk |
| Bank Charges etc | 0 | 10.22 Lk | 4.62 Lk | 3.52 Lk |
| PBDT | 8.76 Cr | 7.82 Cr | 4.74 Cr | 2.92 Cr |
| Depreciation | 5.56 Cr | 5.9 Cr | 5.82 Cr | 6.35 Cr |
| Profit Before Taxation & Exceptional Items | 3.2 Cr | 1.92 Cr | -1.09 Cr | -3.42 Cr |
| Exceptional Income / Expenses | 0 | 0 | -18.63 Cr | 0 |
| Profit Before Tax | 3.2 Cr | 1.92 Cr | -19.72 Cr | -3.42 Cr |
| Provision for Tax | 43.1 Lk | 4.37 Cr | -4.58 Cr | 62.91 Lk |
| Current Income Tax | 52.57 Lk | 92.09 Lk | 0 | 0 |
| Deferred Tax | 1.22 Cr | 3.43 Cr | -4.58 Cr | 62.91 Lk |
| Profit After Tax | 2.77 Cr | -2.44 Cr | -15.14 Cr | -4.05 Cr |
| Consolidated Net Profit | 2.77 Cr | -2.44 Cr | -15.14 Cr | -4.05 Cr |
| Profit Balance B/F | 25.79 Cr | 28.47 Cr | 25.97 Cr | -11.54 Cr |
| Appropriations | 28.55 Cr | 26.03 Cr | 10.83 Cr | -15.59 Cr |
| Other Appropriation | 8.31 Lk | 6.2 Lk | -34.33 Lk | -5.47 Lk |
| Earnings Per Share | 0.43 | -0.38 | -2.33 | -0.52 |
| Adjusted EPS | 0.43 | -0.38 | -2.33 | -0.52 |
CONSOLIDATED CASH FLOW FOR JHS SVENDGAARD LABORATORIES LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 96.78 Lk | 10.3 Lk | -21.84 Cr | -3.43 Cr |
| Adjustment | 6.45 Cr | 17.87 Lk | 26.38 Cr | 5.73 Cr |
| Changes In working Capital | 5.39 Cr | -9.11 Cr | 14.36 Cr | -10.88 Cr |
| Cash Flow after changes in Working Capital | 12.8 Cr | -8.83 Cr | 18.9 Cr | -8.58 Cr |
| Cash Flow from Operating Activities | 12.03 Cr | -9.14 Cr | 18.9 Cr | -8.58 Cr |
| Cash Flow from Investing Activities | -2.23 Cr | -4.7 Cr | 6.23 Cr | -21.73 Cr |
| Cash Flow from Financing Activitie | 10.31 Cr | -1.67 Cr | 8.1 Cr | 2.17 Cr |
| Net Cash Inflow / Outflow | 20.11 Cr | -15.5 Cr | 33.22 Cr | -28.14 Cr |
| Opening Cash & Cash Equivalents | 67.98 Lk | 20.79 Cr | 6.46 Cr | 37.25 Cr |
| Closing Cash & Cash Equivalent | 20.79 Cr | 5.29 Cr | 39.68 Cr | 9.1 Cr |
STANDALONE CASH FLOW FOR JHS SVENDGAARD LABORATORIES LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 3.2 Cr | 1.92 Cr | -19.72 Cr | -3.42 Cr |
| Adjustment | 5.28 Cr | -1.33 Cr | 20.36 Cr | 5.73 Cr |
| Changes In working Capital | 7.72 Cr | -11.56 Cr | 19.57 Cr | -10.88 Cr |
| Cash Flow after changes in Working Capital | 16.2 Cr | -10.97 Cr | 20.21 Cr | -8.58 Cr |
| Cash Flow from Operating Activities | 15.42 Cr | -11.28 Cr | 20.21 Cr | -8.58 Cr |
| Cash Flow from Investing Activities | -5.58 Cr | -95.81 Lk | 9.14 Cr | -21.95 Cr |
| Cash Flow from Financing Activitie | 6.42 Cr | 1.59 Lk | -78.86 Lk | 2.17 Cr |
| Net Cash Inflow / Outflow | 16.26 Cr | -12.22 Cr | 28.56 Cr | -28.35 Cr |
| Opening Cash & Cash Equivalents | 26.67 Lk | 16.53 Cr | 5.48 Cr | 37.22 Cr |
| Closing Cash & Cash Equivalent | 16.53 Cr | 4.31 Cr | 34.04 Cr | 8.87 Cr |
CONSOLIDATED BALANCE SHEET FOR JHS SVENDGAARD LABORATORIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 64.4 Cr | 64.9 Cr | 64.9 Cr | 78.4 Cr |
| Equity - Authorised | 65 Cr | 65 Cr | 65 Cr | 101 Cr |
| Equity - Issued | 64.4 Cr | 64.9 Cr | 64.9 Cr | 78.4 Cr |
| Equity Paid Up | 64.4 Cr | 64.9 Cr | 64.9 Cr | 78.4 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 124.04 Cr | 121 Cr | 107.53 Cr | 91.49 Cr |
| Securities Premium | 103.66 Cr | 104.16 Cr | 96.23 Cr | 110.35 Cr |
| Capital Reserves | 2.42 Cr | 2.42 Cr | 2.42 Cr | -3.08 Cr |
| Profit & Loss Account Balance | 17.7 Cr | 14.12 Cr | 8.68 Cr | -15.93 Cr |
| General Reserves | 6.68 Lk | 6.68 Lk | 6.68 Lk | 6.68 Lk |
| Reserve excluding Revaluation Reserve | 124.04 Cr | 121 Cr | 107.53 Cr | 91.49 Cr |
| Shareholder's Funds | 188.7 Cr | 185.9 Cr | 172.43 Cr | 169.88 Cr |
| Minority Interest | 9.27 Cr | 9.14 Cr | 7.87 Cr | 0 |
| Secured Loans | 36.96 Lk | 38.2 Lk | 23.93 Lk | 11.89 Lk |
| Unsecured Loans | 10 Lk | 10 Lk | 0 | 0 |
| Loans - Others | 10 Lk | 10 Lk | 0 | 0 |
| Deferred Tax Assets / Liabilities | -10.53 Cr | -7.11 Cr | -11.68 Cr | -10.52 Cr |
| Deferred Tax Assets | 14.33 Cr | 12.18 Cr | 16.05 Cr | 16.7 Cr |
| Deferred Tax Liability | 3.8 Cr | 5.07 Cr | 4.37 Cr | 6.18 Cr |
| Other Long Term Liabilities | 5.03 Cr | 6.02 Cr | 16.23 Cr | 2.24 Cr |
| Long Term Provisions | 1.89 Cr | 1.74 Cr | 1.37 Cr | 1.48 Cr |
| Total Non-Current Liabilities | -3.14 Cr | 1.12 Cr | 6.15 Cr | -6.69 Cr |
| Trade Payables | 15.98 Cr | 13.84 Cr | 21.28 Cr | 14.1 Cr |
| Sundry Creditors | 15.98 Cr | 13.84 Cr | 21.28 Cr | 14.1 Cr |
| Other Current Liabilities | 7.01 Cr | 4.86 Cr | 16.66 Cr | 9.12 Cr |
| Advances received from customers | 1.51 Cr | 88.72 Lk | 10.75 Cr | 18.44 Lk |
| Interest Accrued But Not Due | 37,000 | 1.19 Lk | 20,000 | 15,000 |
| Short Term Provisions | 14.4 Lk | 21.48 Lk | 12.11 Lk | 12.31 Lk |
| Total Current Liabilities | 23.13 Cr | 18.91 Cr | 38.06 Cr | 23.34 Cr |
| Total Liabilities | 217.95 Cr | 215.08 Cr | 224.5 Cr | 186.53 Cr |
| Gross Block | 90.53 Cr | 91.28 Cr | 105.22 Cr | 133.18 Cr |
| Less: Accumulated Depreciation | 27.31 Cr | 32.76 Cr | 39.02 Cr | 42.76 Cr |
| Net Block | 63.22 Cr | 58.52 Cr | 66.2 Cr | 90.41 Cr |
| Capital Work in Progress | 8.92 Cr | 19.96 Cr | 8.57 Cr | 81.68 Lk |
| Non Current Investments | 0 | 1.18 Cr | 2.97 Cr | 3.45 Cr |
| Long Term Investment | 0 | 1.18 Cr | 2.97 Cr | 3.45 Cr |
| Quoted | 0 | 1.18 Cr | 2.86 Cr | 2.44 Cr |
| Unquoted | 0 | 0 | 10.63 Lk | 1 Cr |
| Long Term Loans & Advances | 13.23 Cr | 54.33 Cr | 55.49 Cr | 47.66 Cr |
| Other Non Current Assets | 65.91 Lk | 1.87 Cr | 1.24 Cr | 53.04 Lk |
| Total Non-Current Assets | 86.02 Cr | 135.86 Cr | 134.46 Cr | 142.87 Cr |
| Currents Investments | 2.05 Cr | 2.44 Cr | 1.15 Cr | 0 |
| Quoted | 2.05 Cr | 2.44 Cr | 1.15 Cr | 0 |
| Unquoted | 0 | 0 | 10.63 Lk | 1 Cr |
| Inventories | 11.64 Cr | 12.1 Cr | 13.63 Cr | 12.65 Cr |
| Raw Materials | 4.06 Cr | 3.56 Cr | 3.82 Cr | 5.33 Cr |
| Work-in Progress | 1.31 Cr | 2.52 Cr | 1.72 Cr | 1.73 Cr |
| Finished Goods | 2.83 Cr | 2.4 Cr | 2.71 Cr | 1.43 Cr |
| Packing Materials | 3.14 Cr | 2.82 Cr | 4.77 Cr | 3.51 Cr |
| Stores and Spare | 30.07 Lk | 79.62 Lk | 61.93 Lk | 66.7 Lk |
| Sundry Debtors | 58.71 Cr | 18.12 Cr | 20.67 Cr | 12.88 Cr |
| Debtors more than Six months | 0 | 10.16 Cr | 9 Cr | 4.81 Cr |
| Debtors Others | 58.71 Cr | 7.96 Cr | 11.67 Cr | 8.07 Cr |
| Cash and Bank | 21.15 Cr | 6.46 Cr | 39.69 Cr | 10.36 Cr |
| Cash in hand | 17.16 Lk | 42.55 Lk | 67.26 Lk | 18.62 Lk |
| Balances at Bank | 20.98 Cr | 6.04 Cr | 39.02 Cr | 10.18 Cr |
| Other Current Assets | 7.47 Cr | 9.31 Cr | 5.56 Cr | 1.26 Cr |
| Interest accrued and or due on loans | 8.41 Lk | 67.96 Lk | 54.1 Lk | 96.99 Lk |
| Prepaid Expenses | 35.24 Lk | 41.14 Lk | 11.69 Lk | 19.39 Lk |
| Short Term Loans and Advances | 19.94 Cr | 30.52 Cr | 9.23 Cr | 6.51 Cr |
| Advances recoverable in cash or in kind | 25.39 Cr | 14.1 Cr | 3.3 Cr | 4.85 Cr |
| Advance income tax and TDS | 59,000 | 2.15 Lk | 26.12 Lk | 0 |
| Total Current Assets | 120.95 Cr | 78.95 Cr | 89.93 Cr | 43.66 Cr |
| Net Current Assets (Including Current Investments) | 97.82 Cr | 60.04 Cr | 51.87 Cr | 20.33 Cr |
| Miscellaneous Expenses not written off | 10.98 Cr | 26.77 Lk | 11.35 Lk | 0 |
| Total Assets | 217.95 Cr | 215.08 Cr | 224.5 Cr | 186.53 Cr |
| Contingent Liabilities | 3.08 Cr | 4.9 Cr | 2.02 Cr | 1.83 Cr |
| Total Debt | 83.65 Lk | 68.55 Lk | 37.88 Lk | 3.56 Cr |
| Book Value | 27.56 | 28.6 | 26.55 | 21.67 |
| Adjusted Book Value | 27.56 | 28.6 | 26.55 | 21.67 |
STANDALONE BALANCE SHEET FOR JHS SVENDGAARD LABORATORIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 64.4 Cr | 64.9 Cr | 64.9 Cr | 78.4 Cr |
| Equity - Authorised | 65 Cr | 65 Cr | 65 Cr | 101 Cr |
| Equity - Issued | 64.4 Cr | 64.9 Cr | 64.9 Cr | 78.4 Cr |
| Equity Paid Up | 64.4 Cr | 64.9 Cr | 64.9 Cr | 78.4 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 126.83 Cr | 124.86 Cr | 109.92 Cr | 91.89 Cr |
| Securities Premium | 95.73 Cr | 96.23 Cr | 96.23 Cr | 110.35 Cr |
| Capital Reserves | 2.42 Cr | 2.42 Cr | 2.42 Cr | -3.13 Cr |
| Profit & Loss Account Balance | 28.47 Cr | 25.97 Cr | 11.17 Cr | -15.53 Cr |
| General Reserves | 6.68 Lk | 6.68 Lk | 6.68 Lk | 6.68 Lk |
| Reserve excluding Revaluation Reserve | 126.83 Cr | 124.86 Cr | 109.92 Cr | 91.89 Cr |
| Shareholder's Funds | 191.48 Cr | 189.77 Cr | 174.82 Cr | 170.28 Cr |
| Secured Loans | 33.29 Lk | 36.56 Lk | 23.04 Lk | 11.89 Lk |
| Deferred Tax Assets / Liabilities | -6.11 Cr | -2.69 Cr | -6.71 Cr | -10.52 Cr |
| Deferred Tax Assets | 10.36 Cr | 7.22 Cr | 11.37 Cr | 16.7 Cr |
| Deferred Tax Liability | 4.25 Cr | 4.53 Cr | 4.66 Cr | 6.18 Cr |
| Other Long Term Liabilities | 1.62 Cr | 2.86 Cr | 2.48 Cr | 2.24 Cr |
| Long Term Provisions | 1.81 Cr | 1.69 Cr | 1.35 Cr | 1.48 Cr |
| Total Non-Current Liabilities | -2.34 Cr | 2.22 Cr | -2.65 Cr | -6.69 Cr |
| Trade Payables | 15.25 Cr | 13.1 Cr | 20.43 Cr | 14.1 Cr |
| Sundry Creditors | 15.25 Cr | 13.1 Cr | 20.43 Cr | 14.1 Cr |
| Other Current Liabilities | 4.38 Cr | 3.29 Cr | 13.98 Cr | 9.12 Cr |
| Advances received from customers | 35.67 Lk | 65.71 Lk | 10.75 Cr | 16.05 Lk |
| Interest Accrued But Not Due | 37,000 | 29,000 | 20,000 | 15,000 |
| Short Term Provisions | 13.82 Lk | 21.33 Lk | 12.07 Lk | 12.31 Lk |
| Total Current Liabilities | 19.76 Cr | 16.6 Cr | 34.53 Cr | 23.33 Cr |
| Total Liabilities | 208.9 Cr | 208.59 Cr | 206.7 Cr | 186.93 Cr |
| Gross Block | 83.98 Cr | 86.35 Cr | 99.97 Cr | 133.18 Cr |
| Less: Accumulated Depreciation | 25.29 Cr | 30.94 Cr | 36.36 Cr | 42.76 Cr |
| Net Block | 58.69 Cr | 55.41 Cr | 63.6 Cr | 90.41 Cr |
| Capital Work in Progress | 8.85 Cr | 15.83 Cr | 4.44 Cr | 81.68 Lk |
| Non Current Investments | 14.21 Cr | 15.39 Cr | 16.18 Cr | 3.46 Cr |
| Long Term Investment | 14.21 Cr | 15.39 Cr | 16.18 Cr | 3.46 Cr |
| Quoted | 0 | 1.18 Cr | 1.96 Cr | 2.44 Cr |
| Unquoted | 14.21 Cr | 14.21 Cr | 14.21 Cr | 1.01 Cr |
| Long Term Loans & Advances | 25.36 Cr | 35.29 Cr | 14.97 Cr | 48.28 Cr |
| Other Non Current Assets | 21.02 Lk | 1.87 Cr | 1.24 Cr | 53.04 Lk |
| Total Non-Current Assets | 107.31 Cr | 123.78 Cr | 100.43 Cr | 143.5 Cr |
| Unquoted | 14.21 Cr | 14.21 Cr | 14.21 Cr | 1.01 Cr |
| Inventories | 8.71 Cr | 9.15 Cr | 10.86 Cr | 12.65 Cr |
| Raw Materials | 4.06 Cr | 3.56 Cr | 3.82 Cr | 5.33 Cr |
| Work-in Progress | 81.07 Lk | 1.18 Cr | 1.17 Cr | 1.73 Cr |
| Finished Goods | 1.26 Cr | 82.24 Lk | 1.25 Cr | 1.43 Cr |
| Packing Materials | 2.35 Cr | 2.82 Cr | 4.05 Cr | 3.51 Cr |
| Stores and Spare | 22.58 Lk | 76.22 Lk | 58.03 Lk | 66.7 Lk |
| Sundry Debtors | 58.69 Cr | 16.19 Cr | 18.18 Cr | 12.88 Cr |
| Debtors more than Six months | 0 | 8.09 Cr | 8.13 Cr | 4.81 Cr |
| Debtors Others | 58.69 Cr | 8.09 Cr | 10.05 Cr | 8.07 Cr |
| Cash and Bank | 16.88 Cr | 5.48 Cr | 34.04 Cr | 10.13 Cr |
| Cash in hand | 11.26 Lk | 23.49 Lk | 39.53 Lk | 18.61 Lk |
| Balances at Bank | 16.76 Cr | 5.24 Cr | 33.65 Cr | 9.94 Cr |
| Other Current Assets | 7.21 Cr | 6.71 Cr | 2.54 Cr | 1.26 Cr |
| Interest accrued and or due on loans | 2.38 Lk | 67.1 Lk | 2.42 Cr | 96.99 Lk |
| Prepaid Expenses | 18.57 Lk | 23.99 Lk | 2.72 Lk | 19.39 Lk |
| Short Term Loans and Advances | 9.98 Cr | 47.2 Cr | 40.57 Cr | 6.51 Cr |
| Advances recoverable in cash or in kind | 18.95 Cr | 8.11 Cr | 3.15 Cr | 4.85 Cr |
| Total Current Assets | 101.47 Cr | 84.72 Cr | 106.18 Cr | 43.42 Cr |
| Net Current Assets (Including Current Investments) | 81.71 Cr | 68.12 Cr | 71.65 Cr | 20.09 Cr |
| Miscellaneous Expenses not written off | 11.22 Lk | 8.98 Lk | 8.97 Lk | 0 |
| Total Assets | 208.9 Cr | 208.59 Cr | 206.7 Cr | 186.93 Cr |
| Contingent Liabilities | 10.21 Lk | 4.9 Cr | 1.97 Cr | 1.83 Cr |
| Total Debt | 67.24 Lk | 54.67 Lk | 36.17 Lk | 3.56 Cr |
| Book Value | 0 | 29.23 | 26.92 | 21.72 |
| Adjusted Book Value | 29.68 | 29.23 | 26.92 | 21.72 |
FINANCIAL RATIOS (CONSOLIDATED) FOR JHS SVENDGAARD LABORATORIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 0.19 | -0.62 | -2.38 | -0.35 |
| CEPS(Rs) | 1.33 | 0.43 | -1.43 | 0.29 |
| Book NAV/Share(Rs) | 27.56 | 28.6 | 26.55 | 21.67 |
| Tax Rate(%) | -38.71 | 4264.47 | 23.19 | -18.35 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 1.9 | -15.15 | -11.54 | -1.32 |
| EBIT Margin(%) | 2.19 | 1.73 | -21.62 | -4.19 |
| Pre Tax Margin(%) | 0.96 | 0.12 | -22.7 | -4.84 |
| PAT Margin (%) | 1.33 | -4.96 | -17.44 | -5.73 |
| Cash Profit Margin (%) | 8.52 | 3.19 | -9.68 | 3.23 |
| Performance Ratios | ||||
| ROA(%) | 0.6 | -1.98 | -7.63 | -2.01 |
| ROE(%) | 0.76 | -2.36 | -9.37 | -2.36 |
| ROCE(%) | 1.24 | 0.82 | -11.59 | -1.71 |
| Asset Turnover(x) | 0.45 | 0.4 | 0.44 | 0.35 |
| Sales/Fixed Asset(x) | 1.15 | 0.96 | 0.98 | 0.6 |
| Working Capital/Sales(x) | 1.03 | 1.44 | 1.85 | 3.48 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.87 | 1.04 | 1.02 | 1.66 |
| Receivable days | 280.04 | 162.09 | 73.58 | 80.98 |
| Inventory Days | 31.19 | 50.09 | 48.82 | 66.11 |
| Payable days | 98.09 | 139.67 | 150.93 | 237.9 |
| Valuation Parameters | ||||
| PER(x) | 107.2 | 0 | 0 | 0 |
| PCE(x) | 14.94 | 48.27 | -10.95 | 56.16 |
| Price/Book(x) | 0.72 | 0.72 | 0.59 | 0.76 |
| EV/Net Sales(x) | 1.07 | 1.48 | 0.65 | 1.72 |
| EV/Core EBITDA(x) | 11.43 | 14.93 | 11.83 | 36.03 |
| EV/EBIT(x) | 49 | 85.26 | -3.01 | -41 |
| EV/CE(x) | 0.5 | 0.59 | 0.28 | 0.7 |
| M Cap / Sales | 1.28 | 1.55 | 1.06 | 1.81 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -27.57 | -14.4 | 11.54 | -16.53 |
| Core EBITDA Growth(%) | -38.98 | -9.66 | -38.04 | 50.21 |
| EBIT Growth(%) | 156.75 | -32.21 | -1489.72 | 86.75 |
| PAT Growth(%) | 127.65 | -419.53 | -291.09 | 76.84 |
| EPS Growth(%) | 157.27 | -435.47 | -281.66 | 84.11 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0 | 0 | 0 | 0.02 |
| Current Ratio(x) | 5.23 | 4.18 | 2.36 | 1.87 |
| Quick Ratio(x) | 4.73 | 3.54 | 2 | 1.33 |
| Interest Cover(x) | 1.78 | 1.07 | -19.97 | -6.44 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0 | 0.03 |
FINANCIAL RATIOS (STANDALONE) FOR JHS SVENDGAARD LABORATORIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 0.43 | -0.38 | -2.33 | -0.52 |
| CEPS(Rs) | 1.29 | 0.53 | -1.44 | 0.29 |
| Book NAV/Share(Rs) | 29.68 | 29.23 | 26.92 | 21.72 |
| Tax Rate(%) | 13.48 | 226.91 | 23.22 | -18.39 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 3.77 | -15.08 | -9.68 | -1.31 |
| EBIT Margin(%) | 3.76 | 3.02 | -23.58 | -4.18 |
| Pre Tax Margin(%) | 3.29 | 2.4 | -24.07 | -4.83 |
| PAT Margin (%) | 2.85 | -3.05 | -18.48 | -5.72 |
| Cash Profit Margin (%) | 8.58 | 4.31 | -11.37 | 3.24 |
| Performance Ratios | ||||
| ROA(%) | 1.28 | -1.17 | -7.29 | -2.07 |
| ROE(%) | 1.49 | -1.28 | -8.31 | -2.35 |
| ROCE(%) | 1.95 | 1.27 | -10.58 | -1.7 |
| Asset Turnover(x) | 0.45 | 0.38 | 0.39 | 0.36 |
| Sales/Fixed Asset(x) | 1.2 | 0.94 | 0.88 | 0.6 |
| Working Capital/Sales(x) | 1.19 | 1.18 | 1.14 | 3.52 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.83 | 1.06 | 1.14 | 1.66 |
| Receivable days | 289.4 | 170.5 | 76.56 | 80.98 |
| Inventory Days | 22.19 | 40.67 | 44.57 | 66.11 |
| Payable days | 99.95 | 146.47 | 172.38 | 254.55 |
| Valuation Parameters | ||||
| PER(x) | 46.45 | 0 | 0 | 0 |
| PCE(x) | 15.42 | 38.6 | -10.94 | 55.98 |
| Price/Book(x) | 0.67 | 0.7 | 0.58 | 0.75 |
| EV/Net Sales(x) | 1.16 | 1.61 | 0.83 | 1.72 |
| EV/Core EBITDA(x) | 12.19 | 15.44 | 13.3 | 36.03 |
| EV/EBIT(x) | 30.76 | 53 | -3.53 | -41.17 |
| EV/CE(x) | 0.54 | 0.62 | 0.33 | 0.7 |
| M Cap / Sales | 1.33 | 1.67 | 1.24 | 1.81 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -27.07 | -17.59 | 2.52 | -16.53 |
| Core EBITDA Growth(%) | -56.58 | -9.7 | -38.28 | 50.49 |
| EBIT Growth(%) | 15.79 | -33.6 | -897.23 | 86.78 |
| PAT Growth(%) | 56.29 | -188.27 | -520.1 | 76.88 |
| EPS Growth(%) | 47.79 | -187.59 | -520.12 | 76.88 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0 | 0 | 0 | 0.02 |
| Current Ratio(x) | 5.13 | 5.1 | 3.07 | 1.86 |
| Quick Ratio(x) | 4.69 | 4.55 | 2.76 | 1.32 |
| Interest Cover(x) | 8.07 | 4.85 | -48.32 | -6.44 |
| Total Debt/Mcap(x) | 0.01 | 0 | 0 | 0.03 |
SHARE HOLDING PATTERN FOR JHS SVENDGAARD LABORATORIES LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 42.23 | 42.23 | 42.23 | 42.23 | 44.06 | 37.73 | 37.73 | 37.73 | 37.73 | 34.56 |
| FII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.29 | 0.15 | 1.69 |
| DII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public % | 57.77 | 57.77 | 57.77 | 57.77 | 55.94 | 62.27 | 53.11 | 53.76 | 56.07 | 63.75 |
PEER COMPARISON FOR JHS SVENDGAARD LABORATORIES LIMITED
CORPORATE ACTIONS FOR JHS SVENDGAARD
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 06-Aug-2024 | Board Meeting - Quarterly Results | 12-Aug-2024 |
| BSE 30-May-2024 | Board Meeting - Preferential Issue of shares & Issue Of Warrants | 04-Jun-2024 |
| BSE 10-May-2024 | Board Meeting - Audited Results | 18-May-2024 |
| BSE 05-Feb-2024 | Board Meeting - Quarterly Results | 14-Feb-2024 |
| BSE 31-Oct-2023 | Board Meeting - Quarterly Results | 07-Nov-2023 |
| BSE 07-Aug-2023 | Board Meeting - Quarterly Results | 14-Aug-2023 |
| BSE 24-May-2023 | Board Meeting - Audited Results | 30-May-2023 |
| BSE 07-Feb-2023 | Board Meeting - Quarterly Results | 14-Feb-2023 |
| BSE 04-Nov-2022 | Board Meeting - Quarterly Results | 11-Nov-2022 |
| BSE 30-Aug-2022 | Board Meeting - Preferential Issue of shares | 02-Sep-2022 |
| BSE 03-Aug-2022 | Board Meeting - Quarterly Results | 09-Aug-2022 |
| BSE 23-May-2022 | Board Meeting - Audited Results (Revised) | 27-May-2022 |
| BSE 16-May-2022 | Board Meeting - Audited Results | 24-May-2022 |
| BSE 31-Jan-2022 | Board Meeting - Quarterly Results | 08-Feb-2022 |
| BSE 27-Oct-2021 | Board Meeting - Quarterly Results | 02-Nov-2021 |
CORPORATE ANNOUNCEMENTS FOR JHS SVENDGAARD
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 11-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Company has submitted the Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended September 30 2024. |
| BSE 21-Sep-2024 | Intimation FILE | Closure of Trading Window Intimation of Closure of Trading Window for the Quarter ended September 30 2024. |
| BSE 19-Sep-2024 | General Announcements FILE | Update On Business Expansion In Jammu & Kashmir Update under Regulation 30 of SEBI(LODR) Regulations 2015 regarding registration of sale deeds in Jammu & Kashmir for business Expansion. |
| BSE 12-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report JHS Svendgaard Laboratories Limited informed the scrutinizer report of AGM was held on 10th September 2024 |
| BSE 10-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association JHS inform that Members of the company at their meeting held on Tuesday September 10 2024 have approved the Alteration of main object clause of Memorandum of Association. |
| BSE 10-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s Appointment of Lodha & Co LLP Chartered Accountants (FRN: 301051E) as Statutory Auditors of the JHS Svendgaard Laboratories Limited for the period of 5 Years commencing from the conclusion of 20th AGM till the conclusion of 25th AGM. |
| BSE 10-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Proceeding of the 20th Annual General Meeting of JHS Svendgaard Laboratories Limited held on Tuesday September 10 2024. |
| BSE 19-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper publication pursuant to Regulation 30 & 47 confirming dispatch of Notice of 20th AGM of the Company to be held on 10th September 2024 e-voting in respect of resolution contained therein and Annual Report for the Financial Year 2023-24. |
| BSE 17-Aug-2024 | General Announcements FILE | Machine Readable And Searchable Financial Results For The Quarter Ended June 30 2024. Machine Readable and Searchable Financial Results for the Quarter ended June 30 2024. |
| BSE 16-Aug-2024 | General Announcements FILE | Reg. 34 (1) Annual Report. Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations") please find enclosed herewith the Annual Report for the Financial Year 2023-24. |
| BSE 16-Aug-2024 | Intimation FILE | Notice Of 20Th Annual General Meeting Scheduled To Be Held On Tuesday 10Th September 2024. Pursuant to Regulation 30 of the SEBI(LODR)Regulations 2015 we hereby enclose the Notice of 20th Annual General Meeting to be held on Tuesday 10th September 2024. |
| BSE 14-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication JHS Svendgaard Laboratories Limited informed to exchange about the newspaper publication regarding the 20th AGM of the company is schedule to be held on Tuesday 10th September 2024 through OV/OAVM . |
| BSE 14-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication JHS Svendgaard Laboratories Limited has informed to exchange about the newspaper publication of Financial results for the quarter ended 30th June 2024 |
| BSE 12-Aug-2024 | Outcome FILE | JHS Informed The Exchange Regarding The Consideration And Approval Of Financials Results For The Quarter Ended 30Th June 2024 At Its Board Meeting Held On 12Th August 2024. JHS informed the exchange regarding the consideration and approval of Financials Results (Standalone and Consolidated) for the quarter ended 30th June 2024 at its Board Meeting held on 12th August 2024. |
| BSE 12-Aug-2024 | Outcome FILE | Board Meeting Outcome for JHS Informed The Exchange Regarding The Consideration And Approval Of Financials Results For The Quarter Ended 30Th June 2024 At Its Board Meeting Held On 12Th August 2024. JHS informed the exchange regarding the consideration and approval of Financials Results (Standalone and Consolidated) for the quarter ended 30th June 2024 at its Board Meeting held on 12th August 2024. |
| BSE 06-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release for fund raising through Preferential Issue. |
| BSE 06-Aug-2024 | Intimation FILE | Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results For The Quarter Ended 30Th June 2024. JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the un-audited Financial Results (standalone and consolidated) for the quarter ended 30th June 2024. |
| BSE 06-Aug-2024 | General FILE | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nikhil Nanda |
| BSE 03-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment JHS hereby inform the exchange that the Board of Directors at their meeting held on August 03 2024 has considered and approved the allotment of equity shares and Fully convertible warrants. |
| BSE 02-Aug-2024 | General FILE | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sixth Sense India Opportunities II |
| BSE 13-Jul-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 This is to inform you that the Company has submitted Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participant) Regulations 2018 for the quarter ended June 30 2024. |
| BSE 07-Jul-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report JHS has submitted the Exchange a Copy of Scrutinizers Report along with Voting Rights of the Extra ordinary General Meeting held on 4th July 2024. |
| BSE 04-Jul-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of EGM JHS has informed the Exchange regarding the Proceedings of the Extra-Ordinary General Meeting held on 4th July 2024 for the approval of issue of equity shares and convertible warrants on Preferential basis. |
| BSE 24-Jun-2024 | General Announcements FILE | Announcement Under Regulation 30 Of SEBI(LODR) Regulations 2015 Regarding The Intimation Of Trading Approval Of JHS Svendgaard Retail Ventures Limited. Intimation of receipt of Trading Approval from the JHS Svendgaard Retail Ventures Limited. |
| BSE 24-Jun-2024 | Intimation FILE | Closure of Trading Window Intimation of Closure of Trading window for the quarter ended 30th June 2024. |
| BSE 21-Jun-2024 | General Announcements FILE | Intimation Regarding The Expansion Of The Company Business Operations. In reference to the Regulation 30 of SEBI(LODR) Regulations 2015 the company wish to inform you that the company decided to expand its business operation in Union Territory Jammu & Kashmir. |
| BSE 15-Jun-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s JHS SVENDGAARD LABORATORIES LIMITED informed the Exchange regarding the Appointment of M/s Lodha & Co LLP Chartered Accountant as a Statutory Auditor of the Company. |
| BSE 12-Jun-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication of Notice of Extra-Ordinary General Meeting to be held on 04th July 2024. |
| BSE 10-Jun-2024 | Intimation FILE | JHS SVENDGAARD LABORATORIES LIMITED Has Informed The Exchange About Notice Of Shareholders Meeting For Extra-Ordinary Meeting To Be Held On 04-Jul-2024. JHS SVENDGAARD LABORATORIES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Extra-ordinary Meeting to be held on 04-Jul-2024. |
| BSE 04-Jun-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Preferential Issue The Board in its meeting held today approved Preferential issue of Equity shares & warrants. |
INSIDER TRADING FOR JHS SVENDGAARD
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| No Insider trading details found | |||
BULK BLOCK DEALS FOR JHS SVENDGAARD LABORATORIES LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| No Bulk Block details found | |||
DIVIDEND BY JHS SVENDGAARD LABORATORIES LIMITED
No dividend details found
SPLIT / BONUS BY JHS SVENDGAARD LABORATORIES LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
